您要查找的是不是：
- compound clopidogrel bisulfate tablet 复方硫酸氢氯吡格雷片
- Buy Naproxen, Clopidogrel Bisulfate, Valacyclovir Hcl, Diltiazem Hcl. United States 国际长途打美国0.;23元;英国0
- clopidogrel bisulfate 硫酸氢氯吡格雷
- It shows that sodium bisulfate is active. 结果表明,硫酸氢钠的催化活性良好。
- Of 804 patients, 105 (13%) were not responsive to clopidogrel. 在804名患者中有105位（13%25）对氯吡格雷无效。
- Ethyl lactate was synthesized with sodium bisulfate. 采用硫酸氢钠为催化剂合成乳酸乙酯。
- Background: Response variability to clopidogrel therapy has been demonstrated. 背景：已有研究显示氯吡格雷治疗反应的变异性。
- Sodium bisulfate is an excellent catalyst for synthesizing butanone 1,2-propan. 以一水合硫酸氢钠为多相催化剂,由丁酮和1,2-丙二醇反应合成了丁酮1,2-丙二醇缩酮。
- Benzyl butyrate was synthesized by using potassium bisulfate as the ca talyst. 以硫酸氢钾为催化剂,丁酸和苄醇为原料合成丁酸苄酯。
- Isoamyl butyrate was synthesized by using potassium bisulfate as the catalyst. 以硫酸氢钾为催化剂,正丁酸和异戊醇为原料合成了正丁酸异戊酯。
- Background: Clopidogrel is an anti-platelet agent which causes an increase in bleeding time. 背景：氯吡格雷是一种导致凝血时间延长的抗血小板药物。
- Background: No data exist about the impact of nonresponsieness to clopidogrel on the risk of DES thrombosis. 背景：没有数据说明关于氯吡格雷无效对药物洗脱支架血栓形成风险的影响。
- Conclusion Potassium bisulfate is an excellent catalyst for the synthesis of butyl lactate. 结论硫酸氢钾是合成乳酸丁酯的良好催化剂。
- Background: No data exist about the impact of nonresponsiveness to clopidogrel on the risk of DES thrombosis. 背景：没有数据说明关于氯吡格雷无效对药物洗脱支架血栓形成风险的影响。
- OBJECTIVE: To provide information for clinical rational usage of ticlopidine and clopidogrel. 目的:为临床合理使用噻氯吡定和氯吡格雷提供参考。
- Using sodium bisulfate as the catalyst,butyl butyrate was synthesized from butyric acid and butanol. 以硫酸氢钠为催化剂,丁酸与丁醇为原料合成了丁酸丁酯。
- Long-term clopidogrel therapy alone may not achieve adequate inhibition for PCI. 仅长期氯吡格雷治疗可能达不到PCI手术所需的充分血小板抑制。
- Objective To study the catalytic activity of potassium bisulfate in synthesizing hexyl hexanoate. 目的研究硫酸氢钾在合成己酸己酯工艺中的催化性能。
- The progress of synthesis research work of clopidogrel is briefly reviewed,compared and evaluated in this article. 本文简要综述氯吡格雷的一些合成方法,并进行对比分析和简单评价。
- The antiplatelet regimen for standard group was dual antiplatelet therapy with aspirin and clopidogrel. 标准组所有病例均采用标准阿司匹林、氯吡格雷两联抗血小板治疗；
